The old book doesn’t look like much. Its red fabric cover is faded. The edges of the pages have yellowed, and there are no photos or illustrations inside — just page after page bearing the signatures of eminent people, including world-renowned scientists who changed the course of history.

Dr. Odunsi and his colleagues observed that the tumors of some patients were full of T cells that had managed to work their way inside the tumor. When there were many of these T cells, the patients tended to live longer.

Surgical advances, such as video-assisted thoracoscopic surgery (VATS), have replaced the Chamberlain procedure and offer the surgeon a better way to examine the lungs, determine the extent of the disease and get higher-quality biopsies.

A combination of two immunotherapy drugs shows promise in treating patients with skin cancer that has spread to the brain, according to a study published this week the New England Journal of Medicine.

Research and patient advocacy revolutionized breast cancer care in the 1970s, giving women a greater voice in their treatment.

Not all patients respond to all types of immunotherapies. So how can doctors identify which treatments have the best chance of working in a specific patient? How can they quickly zero in on the best options on a list of immunotherapies that grows longer every day?

It can be difficult to make decisions, especially when you’re faced with a cancer diagnosis. For most cancers, there are many treatment options, depending on the type and extent of the disease, any other health conditions you have and other treatments you have received.